NKX3-1 and cancer: These results, as well as additional experiments comparing the efficiency of different Cre drivers (Extended Data Fig. 4 and Supplementary Note 2), lead us to conclude that ERG+ cancers preferentially initiate in Nkx3.1+ BasalLum cells.